A B C D E F G H I J K L M N O P Q R S T U V W X Y Z #

MDMA/MDA, Quantitative, Urine

Test Code
MDMA


Includes
MDA, MDMA, MDEA


Preferred Specimen
20 mL random urine collected in a plastic leak-proof container - no preservatives


Minimum Volume
5 mL


Transport Container
Plastic urine container


Transport Temperature
Refrigerated (cold packs)


Specimen Stability
Room temperature: 14 days
Refrigerated: 14 days
Frozen: 30 days


Reject Criteria (Eg, hemolysis? Lipemia? Thaw/Other?)
Preserved urine


Methodology
Mass Spectrometry (MS)

FDA Status
This test was developed and its analytical performance characteristics have been determined by Quest Diagnostics. It has not been cleared or approved by FDA. This assay has been validated pursuant to the CLIA regulations and is used for clinical purposes.

Setup Schedule
Tuesday-saturday


Report Available
3-5 days


Reference Range
MDA <200 ng/mL
MDMA <200 ng/mL
MDEA <200 ng/mL


Clinical Significance
This test is designed to detect the use of the stimulant/ hallucinogen Methylenedioxymethamphetamine (MDMA, XTC, Ecstasy) and its metabolite Methylenedioxyamphetamine (MDA).




The CPT Codes provided in this document are based on AMA guidelines and are for informational purposes only. CPT coding is the sole responsibility of the billing party. Please direct any questions regarding coding to the payor being billed. Any Profile/panel component may be ordered separately. Reflex tests are performed at an additional charge.